Age trends in the prevalence of cervical squamous intraepithelial lesions among HIV-positive women in Cameroon: A cross-sectional study

被引：8
作者：
Atashili J. [1 ,2 ]
Miller W.C. [3 ]
Smith J.S. [3 ]
Ndumbe P.M. [1 ,2 ]
Ikomey G.M. [1 ,2 ]
Eron J. [3 ]
Rinas A.C. [3 ]
Myers E. [3 ]
Adimora A.A. [3 ]
机构：
[1] University of Buea, Molyko Buea
[2] University of Yaounde I, Yaounde
[3] University of North Carolina at Chapel Hill, Chapel Hill, NC
来源：
BMC Research Notes | / 5卷 / 1期
关键词：
Cervical Cancer; Human Papilloma Virus; Precancerous Lesion; Prevalence Difference; Atypical Squamous Cell;
D O I：
10.1186/1756-0500-5-590
中图分类号：
学科分类号：
摘要：
Background: Cervical squamous intra-epithelial lesions (SIL) are more frequent in HIV-positive women overall. However the appropriate age at which to begin and end cervical cancer screening for early detection of lesions in HIV-positive women is not clear. We assessed the age-specific prevalence of any SIL and SIL requiring colposcopy in HIV-positive women in Cameroon. Methods. We enrolled, interviewed and conducted conventional cervical cytology in 282 women, aged 19-68 years, initiating antiretroviral therapy in three clinics in Cameroon. In bivariable analyses, the crude relationship between age and the presence of lesions was assessed using locally weighted regression (LOWESS) methods. In multivariate analyses, generalized linear models with prevalence as the outcome, an identity link and a binomial distribution, were used to estimate prevalence differences. Bias analyses were conducted to assess the potential effect of inaccuracies in cytology. Results: SIL were detected in 43.5% of the 276 women with satisfactory samples, 17.8% of whom had ASC-H/HSIL. On average, women aged 26 to 59 tended to have a slightly higher prevalence of any SIL than other women (Prevalence difference PD: 6.5%; 95%CI: -11.4, 24.4%). This PD was a function of CD4 count (heterogeneity test p-value =0.09): amongst patients with CD4 counts less than 200cells/uL, the prevalence was higher in patients aged 26-59, while there was essentially no difference amongst women with CD4 counts greater than 200 cells/uL. ASC-H/HSIL were present in women as young as 19 and as old as 62. Overall the prevalence of ASC-H/HSIL increased by 0.7% (95%CI: -3.8%, 5.1%) per decade increase in age. Conclusion: Both severe and less severe lesions were prevalent at all ages suggesting little utility of age-targeted screening among HIV-positive women. Nevertheless, the long-term evolution of these lesions needs to be assessed in prospective studies. © 2012 Atashili et al.; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 29 条
  • [1] Stewart B.W., Kleihues P., Cancers of the female reproductive tract, World Cancer Report, (2003)
  • [2] Saslow D., Runowicz C.D., Solomon D., Moscicki A.-B., Smith R.A., Eyre H.J., Cohen C., American Cancer Society guideline for the early detection of cervical neoplasia and cancer, Ca-A Cancer Journal for Clinicians, 52, 6, pp. 342-362, (2002)
  • [3] Cervical Cytology Screening, ACOG Practice Bulletin No. 45. ACOG, 102, pp. 417-427, (2003)
  • [4] Screening for Cervical Cancer, (2003)
  • [5] Comprehensive Cervical Control: A Guide to Essential Practice, (2006)
  • [6] Sun X.-W., Kuhn L., Ellerbrock T.V., Chiasson M.A., Bush T.J., Wright Jr. T.C., Human papillomavirus infection in women infected with the human immunodeficiency virus, New England Journal of Medicine, 337, 19, pp. 1343-1349, (1997)
  • [7] Owens D.K., Edwards D.M., Shachter R.D., Population effects of preventive and therapeutic HIV vaccines in early- and late-stage epidemics, AIDS, 12, 9, pp. 1057-1065, (1998)
  • [8] Cu-Uvin S., Hogan J.W., Warren D., Klein R.S., Peipert J., Schuman P., Holmberg S., Anderson J., Schoenbaum E., Vlahov D., Mayer K.H., Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women, Clinical Infectious Diseases, 29, 5, pp. 1145-1150, (1999)
  • [9] Massad L.S., Ahdieh L., Benning L., Minkoff H., Greenblatt R.M., Watts H., Miotti P., Anastos K., Moxley M., Muderspach L.I., Melnick S., Evolution of cervical abnormalities among women with HIV-1: Evidence from surveillance cytology in the Women's Interagency HIV Study, Journal of Acquired Immune Deficiency Syndromes, 27, 5, pp. 432-442, (2001)
  • [10] Palefsky J., HPV infection and HPV-associated neoplasia in immunocompromised women, Int J Gynaecol Obstet, 94, SUPPL. 1, (2006)
123